Cumberland Pharmaceuticals Inc.
CPIX
$4.49
-$0.27-5.67%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 69.75% | -47.16% | -224.47% | -1,112.64% | -157.89% |
| Total Depreciation and Amortization | 31.13% | -5.76% | -4.84% | 0.56% | 165.63% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -112.96% | -1.42% | -107.48% | 88.73% | 391.00% |
| Change in Net Operating Assets | -16.33% | -11.36% | -189.04% | -44.01% | -56.24% |
| Cash from Operations | 83.12% | -61.54% | -116.34% | -50.66% | -71.41% |
| Capital Expenditure | 95.28% | 71.00% | 90.03% | 61.23% | -131.73% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -107.92% | 589.26% | -60.98% | 75.30% | 138.94% |
| Cash from Investing | -110.28% | 299.37% | 51.65% | 66.65% | 140.67% |
| Total Debt Issued | -28.57% | 41.34% | 37.50% | 37.50% | 24.19% |
| Total Debt Repaid | 19.44% | -37.36% | -0.63% | 5.26% | -1.81% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 47.94% | 51.02% | 17.57% | -32.34% | 0.37% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 59.92% | 3.93% | 3.13% | 56.93% | -6.23% |
| Cash from Financing | 7.31% | 39.18% | 90.55% | 236.12% | 46.52% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 368.06% | -50.44% | -165.06% | 106.73% | -186.09% |